Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Batch Verification of Dispensed Materials – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Batch Verification of Dispensed Materials – V 2.0

Standard Operating Procedure for Batch Verification of Dispensed Materials


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/107/2025
Supersedes SOP/SIM/107/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for batch-wise verification of dispensed raw materials prior to use in sterile injectable manufacturing, ensuring correct material identity, quantity, and traceability.

2. Scope

This procedure applies to all batches of raw materials dispensed and released for production of

sterile injectable products.

3. Responsibilities

  • Dispensing Operator: Perform physical verification and record observations.
  • Production Supervisor: Cross-verify dispensed material details with manufacturing order.
  • QA Executive: Review and release batch for manufacturing after verification.
See also  Sterile Injectable Manufacturing: SOP for Batch Release of Injectable Products - V 2.0

4. Accountability

The Head of Production is accountable for overall implementation and compliance.

5. Procedure

5.1 Material Batch Verification Steps

  1. Receive dispensed materials in the staging area with their labels, status tags, and dispensing records.
  2. Physically verify the following for each material:
    • Material Name
    • Material Code
    • Batch/Lot Number
    • Dispensed Quantity
    • Status label (Approved, Quarantined, or Rejected)
  3. Match the above details with the Batch Manufacturing Record (BMR) and Dispensing Sheet (Annexure-1).
  4. Record discrepancies, if any, and notify QA immediately.
  5. Ensure reconciliation of issued vs required quantities.

5.2 Label Integrity

  • Ensure all containers are properly labeled with legible and validated barcodes (if applicable).
  • Cross-check the expiry date and retest date mentioned on labels.
See also  Quality Control: SOP for Periodic Calibration of QC Equipment - V 2.0

5.3 QA Verification

  1. QA personnel shall review the entries and physical status of each dispensed item.
  2. Complete the Batch Verification Checklist (Annexure-2).
  3. QA signs the release approval on the Dispensing Sheet and BMR.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Dispensing Sheet – Annexure-1
  2. Batch Verification Checklist – Annexure-2
  3. Dispensed Material Logbook – Annexure-3

8. References

  • GMP Guidelines – WHO, EU Annex 1
  • Company Quality Management Manual

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Dispensing Officer QA Executive Head QA
Department Production Quality Assurance Quality Assurance
See also  Manufacturing: SOP for Training Personnel on In-Process Monitoring - V 2.0

11. Annexures

Annexure-1: Dispensing Sheet

Material Batch No. Code Qty Verified By
Mannitol MN240621 RM004 15.0 kg S. Patil

Annexure-2: Batch Verification Checklist

  • Is material labeled correctly? □Yes □No
  • Does batch number match? □Yes □No
  • Is status label applied and accurate? □Yes □No
  • Any discrepancy noted? □Yes □No (Details)

Annexure-3: Dispensed Material Logbook

Include: Date, Material Name, Code, Batch No., Quantity, Dispensed By, Verified By, Remarks

Revision History

Revision Date Revision No. Details Reason Approved By
20/02/2022 1.0 Initial issue New SOP QA Head
18/06/2025 2.0 Checklist and reconciliation step added Process Update QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Cleaning of Manufacturing Vessels and Accessories – V 2.0
Next Post: Elixir Department: SOP for Online Viscosity Measurement – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version